The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move reflecting continued momentum in the IPO market, iHerb has selected JPMorgan and Morgan Stanley as lead underwriters for its planned initial public offering, targeting a $500 million raise. According to reports, the appointment marks concrete progress in the company's preparations for a public listing.
iHerb is a leading online platform for dietary supplements and health products, serving a global customer base. The announcement comes at a time when the IPO market is seeing a notable recovery, with rising investor interest in high-growth e-commerce companies.
No specific exchange or price range has been disclosed yet, as the deal remains in preparation. iHerb is expected to begin its investor roadshow in the coming months, monitoring market conditions and assessing available opportunities.
Sign in to access this content
Sign In